December 2008

Multi-Modality Diagnosis Heading for Lab Medicine

Clinical Laboratory Trends / Robert Michel

CEO Summary: At the upcoming Molecular Summit in Philadelphia on February 10-11, 2009, pathologists, molecular imaging experts, and informaticians will share the latest developments on the integration of in vivo (imaging) and in vitro (pathology) diagnostics. A major theme will be discussion about multi-modality diagnostics and how this new discipline—driven by advances in genetics and […]

To access this post, you must purchase The Dark Report.

Multi-Modality Diagnosis Heading for Lab Medicine Read More »

LabCorp Talks to Its Clients About Service Enhancements

Clinical Laboratory Trends / Robert Michel

BOTH NATIONAL LABORATORIES now face a future where growth is not likely to come from a steady stream of sizeable laboratory acquisitions. That makes service enhancements a more important way to protect market share and build client loyalty. At Laboratory Corporation of America, this strategy can be seen in a letter the company recently distributed

To access this post, you must purchase The Dark Report.

LabCorp Talks to Its Clients About Service Enhancements Read More »

Momentum Continues for Digital Pathology

Digital Pathology / Robert Michel

CEO SUMMARY: Last month, digital imaging in pathology gained additional momentum with the latest FDA clearance. Aperio Technologies, Inc., now has FDA clearance to market its slide scanning system for reading digital progesterone receptor (PR) slides on a computer monitor. Aperio plans to file an application next year with the FDA for clearance to use

To access this post, you must purchase The Dark Report.

Momentum Continues for Digital Pathology Read More »

December 01, 2008 “Intelligence: Late Breaking Lab News”

Late Breaking Lab News / Robert Michel

Having grown to over $1 billion in revenue, Inverness Medical Innovations, Inc. of Waltham, Massachusetts, is newest of the in vitro diagnostics (IVD) companies to achieve size and scale. One of its more interesting products is an in-home system that allows warfarin patients to test themselves and produce PT/INR results. Inverness’ INRatio2 PT/INR Monitoring System

To access this post, you must purchase The Dark Report.

December 01, 2008 “Intelligence: Late Breaking Lab News” Read More »